Cancer

Title
Comparison of a Combination of Chemotherapy Drugs to the Standard Chemotherapy Treatment for Uterine Cancer
Trial Number
202313111809
Number of Participants
424
Principal Investigator
Eligibility

Participants must be women 18 years of age or older with a newly diagnosed Stage I - IV, persistent or recurrent (including unstaged) uterine carcinosarcoma (malignant mixed mullerian tumor-MMMT) and be chemotherapy naïve as directed against uterine carcinosarcoma.

Purpose

The purpose of this study is to compare a different chemotherapy combination with the current standard chemotherapy treatment for uterine cancer.

Enrollment

(708) 327-3222

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.